Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Sphere 3D Corp. stock logo
ANY
Sphere 3D
$0.56
+4.0%
$0.52
$0.36
$1.90
$14.56M3.56577,054 shs425,954 shs
BTC Digital Ltd. stock logo
BTCT
BTC Digital
$4.17
+2.2%
$4.02
$1.32
$26.58
$13.75M4.231.55 million shs208,289 shs
NeuroBo Pharmaceuticals, Inc. stock logo
NRBO
NeuroBo Pharmaceuticals
$0.82
-3.2%
$1.40
$2.08
$5.30
$7.09M-0.2648,953 shs129,679 shs
Prestige Wealth Inc. stock logo
PWM
Prestige Wealth
$0.36
+1.2%
$0.47
$0.31
$2.70
$5.21M3.12610,980 shs5,493 shs
Free Today: Your Guide to Smarter Options Trades Cover

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Sphere 3D Corp. stock logo
ANY
Sphere 3D
+3.96%+19.43%+22.73%-43.76%-51.63%
BTC Digital Ltd. stock logo
BTCT
BTC Digital
+2.21%+22.29%-2.80%-44.62%+57.95%
NeuroBo Pharmaceuticals, Inc. stock logo
NRBO
NeuroBo Pharmaceuticals
+4.55%+15.02%-46.20%-56.19%-72.58%
Prestige Wealth Inc. stock logo
PWM
Prestige Wealth
+2.86%+9.56%-23.89%-73.72%-68.97%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Sphere 3D Corp. stock logo
ANY
Sphere 3D
2.6775 of 5 stars
3.55.00.00.02.70.00.6
BTC Digital Ltd. stock logo
BTCT
BTC Digital
1.2753 of 5 stars
0.04.00.00.03.30.01.3
NeuroBo Pharmaceuticals, Inc. stock logo
NRBO
NeuroBo Pharmaceuticals
N/AN/AN/AN/AN/AN/AN/AN/A
Prestige Wealth Inc. stock logo
PWM
Prestige Wealth
0.8653 of 5 stars
0.05.00.00.03.30.00.0
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Sphere 3D Corp. stock logo
ANY
Sphere 3D
3.00
Buy$3.00439.37% Upside
BTC Digital Ltd. stock logo
BTCT
BTC Digital
0.00
N/AN/AN/A
NeuroBo Pharmaceuticals, Inc. stock logo
NRBO
NeuroBo Pharmaceuticals
3.00
Buy$10.001,115.66% Upside
Prestige Wealth Inc. stock logo
PWM
Prestige Wealth
0.00
N/AN/AN/A

Current Analyst Ratings Breakdown

Latest PWM, NRBO, BTCT, and ANY Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/4/2025
Sphere 3D Corp. stock logo
ANY
Sphere 3D
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$3.00 ➝ $3.00
(Data available from 4/26/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Sphere 3D Corp. stock logo
ANY
Sphere 3D
$16.61M0.88N/AN/A$1.85 per share0.30
BTC Digital Ltd. stock logo
BTCT
BTC Digital
$8.48M1.62$1.62 per share2.58$9.27 per share0.45
NeuroBo Pharmaceuticals, Inc. stock logo
NRBO
NeuroBo Pharmaceuticals
N/AN/AN/AN/A$1.50 per shareN/A
Prestige Wealth Inc. stock logo
PWM
Prestige Wealth
$639.91K8.14N/AN/A$0.34 per share1.06
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Sphere 3D Corp. stock logo
ANY
Sphere 3D
-$23.41M-$0.52N/AN/AN/A-50.87%-49.54%-34.72%5/12/2025 (Estimated)
BTC Digital Ltd. stock logo
BTCT
BTC Digital
-$2.82MN/A0.00N/AN/AN/AN/AN/A5/21/2025 (Estimated)
NeuroBo Pharmaceuticals, Inc. stock logo
NRBO
NeuroBo Pharmaceuticals
-$12.47MN/A0.00N/AN/AN/A-189.12%-122.31%5/7/2025 (Estimated)
Prestige Wealth Inc. stock logo
PWM
Prestige Wealth
-$6.88MN/A0.00N/AN/AN/AN/AN/A

Latest PWM, NRBO, BTCT, and ANY Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/12/2025N/A
Sphere 3D Corp. stock logo
ANY
Sphere 3D
-$0.26N/AN/AN/A$3.09 millionN/A
3/28/2025Q4 2024
Sphere 3D Corp. stock logo
ANY
Sphere 3D
-$0.27-$0.29-$0.02-$0.36$6.72 million$2.64 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Sphere 3D Corp. stock logo
ANY
Sphere 3D
N/AN/AN/AN/AN/A
BTC Digital Ltd. stock logo
BTCT
BTC Digital
N/AN/AN/AN/AN/A
NeuroBo Pharmaceuticals, Inc. stock logo
NRBO
NeuroBo Pharmaceuticals
N/AN/AN/AN/AN/A
Prestige Wealth Inc. stock logo
PWM
Prestige Wealth
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Sphere 3D Corp. stock logo
ANY
Sphere 3D
N/A
4.09
4.09
BTC Digital Ltd. stock logo
BTCT
BTC Digital
N/A
2.14
2.14
NeuroBo Pharmaceuticals, Inc. stock logo
NRBO
NeuroBo Pharmaceuticals
N/A
2.41
2.41
Prestige Wealth Inc. stock logo
PWM
Prestige Wealth
N/A
1.12
1.12

Institutional Ownership

CompanyInstitutional Ownership
Sphere 3D Corp. stock logo
ANY
Sphere 3D
17.28%
BTC Digital Ltd. stock logo
BTCT
BTC Digital
7.32%
NeuroBo Pharmaceuticals, Inc. stock logo
NRBO
NeuroBo Pharmaceuticals
1.37%
Prestige Wealth Inc. stock logo
PWM
Prestige Wealth
7.68%

Insider Ownership

CompanyInsider Ownership
Sphere 3D Corp. stock logo
ANY
Sphere 3D
5.59%
BTC Digital Ltd. stock logo
BTCT
BTC Digital
0.63%
NeuroBo Pharmaceuticals, Inc. stock logo
NRBO
NeuroBo Pharmaceuticals
1.05%
Prestige Wealth Inc. stock logo
PWM
Prestige Wealth
N/A
CompanyEmployeesShares OutstandingFree FloatOptionable
Sphere 3D Corp. stock logo
ANY
Sphere 3D
2026.18 million24.03 millionOptionable
BTC Digital Ltd. stock logo
BTCT
BTC Digital
163.30 million3.28 millionNot Optionable
NeuroBo Pharmaceuticals, Inc. stock logo
NRBO
NeuroBo Pharmaceuticals
108.62 million8.53 millionNot Optionable
Prestige Wealth Inc. stock logo
PWM
Prestige Wealth
414.47 millionN/ANot Optionable

Recent News About These Companies

Prestige Wealth Inc. Announces COO Resignation
Prestige Wealth receives noncompliance notification from Nasdaq
Prestige Wealth Inc. to Change Business Address
Prestige Wealth’s InnoSphere integrates DeepSeek

New MarketBeat Followers Over Time

Media Sentiment Over Time

Sphere 3D stock logo

Sphere 3D NASDAQ:ANY

$0.56 +0.02 (+3.96%)
Closing price 04/25/2025 04:00 PM Eastern
Extended Trading
$0.56 +0.01 (+1.04%)
As of 04/25/2025 07:56 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Sphere 3D Corp. engages in the bitcoin mining business. It is involved with digital asset mining pool operators to provide computing power to the mining pools. The company is based in Stamford, Connecticut.

BTC Digital stock logo

BTC Digital NASDAQ:BTCT

$4.17 +0.09 (+2.21%)
Closing price 04/25/2025 04:00 PM Eastern
Extended Trading
$4.25 +0.08 (+1.92%)
As of 04/25/2025 07:57 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

BTC Digital Ltd. a crypto asset technology company engages in bitcoin mining business. It is also involved in mining machines resale and rental business. The company was formerly known as Meten Holding Group Ltd. and changed its name to BTC Digital Ltd. in August 2023. The company was founded in 2006 and is headquartered in Shenzhen, China.

NeuroBo Pharmaceuticals stock logo

NeuroBo Pharmaceuticals NASDAQ:NRBO

$0.82 -0.03 (-3.22%)
As of 04/25/2025

NeuroBo Pharmaceuticals, Inc., a clinical-stage biotechnology company focuses on developing and commercializing novel pharmaceuticals to treat cardiometabolic diseases. It develops DA-1241, a novel G-Protein-Coupled Receptor 119 agonist with development optionality as a standalone and/or combination therapy that is in Phase 2a clinical trial for metabolic dysfunction-associated steatohepatitis (MASH), and has completed Phase 1 clinical trial for the treatment of type 2 diabetes mellitus (T2DM); and DA-1726, a novel oxyntomodulin analogue functioning as a GLP-1 receptor and glucagon receptor dual agonist, which is in preclinical development for the treatment of obesity. The company's therapeutic programs include ANA001, a proprietary oral niclosamide formulation for the treatment of patients with moderate COVID-19; NB-01 for the treatment of painful diabetic neuropathy; NB-02 for the treatment of cognitive impairment; and Gemcabene for the treatment of dyslipidemia. It has a license agreement with Pfizer Inc. for the research, development, manufacture, and commercialization of Gemcabene. NeuroBo Pharmaceuticals, Inc. is headquartered in Cambridge, Massachusetts.

Prestige Wealth stock logo

Prestige Wealth NASDAQ:PWM

$0.36 +0.00 (+1.18%)
Closing price 04/25/2025 03:51 PM Eastern
Extended Trading
$0.34 -0.02 (-5.28%)
As of 04/25/2025 06:39 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Prestige Wealth Inc., through its subsidiaries, provides wealth management and asset management services. It assists its clients in identifying and purchasing wealth and asset management products. The company offers its services primarily for high net worth and ultra-high net worth individuals, including business owners, executives, heirs of rich families, and other affluent individuals in Asia primarily in the mainland China or Hong Kong. The company was incorporated in 2018 and is based in Central, Hong Kong. Prestige Wealth Inc. is a subsidiary of Prestige Financial Holdings Group Limited.